Other Income & Expense
Other Charges
Vertex Pharmaceuticals Other Charges increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$17.60M to $0.00. Over 3 years (FY 2021 to FY 2024), Other Charges shows a downward trend with a 160.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase suggests unexpected non-operating costs or one-time financial hits, which can negatively impact net income.
Detailed definition
This metric captures non-operating financial expenses that do not fall under standard categories like interest or taxes....
Peer comparison
Often found in the non-operating section of the income statement; peers may label these as 'other expenses' or 'sundry charges'.
Metric ID:
hon_other_chargesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.10M | $42.40M | $7.10M | -$72.80M | -$78.10M | $17.20M | -$31.10M | $1.30M | $1.60M | -$15.90M | -$9.80M | -$31.20M | -$23.10M | -$16.90M | -$14.90M | -$17.60M | $13.20M | -$9.80M | $0.00 |
| QoQ Change | — | +423.5% | -83.3% | <-999% | -7.3% | +122.0% | -280.8% | +104.2% | +23.1% | <-999% | +38.4% | -218.4% | +26.0% | +26.8% | +11.8% | -18.1% | +175.0% | -174.2% | +100.0% |
| YoY Change | — | — | — | — | <-999% | -59.4% | -538.0% | +101.8% | +102.0% | -192.4% | +68.5% | <-999% | <-999% | -6.3% | -52.0% | +43.6% | +157.1% | +42.0% | +100.0% |
Range-$78.10M – $42.40M
CAGR-100.0%
Avg YoY Growth-356.1%
Median YoY Growth-6.3%
Other Charges at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other charges?
- Vertex Pharmaceuticals (VRTX) reported other charges of $0.00 in Q1 2026.
- How has Vertex Pharmaceuticals's other charges changed year-over-year?
- Vertex Pharmaceuticals's other charges increased by 100.0% year-over-year, from -$17.60M to $0.00.
- What is the long-term trend for Vertex Pharmaceuticals's other charges?
- Over 3 years (2021 to 2024), Vertex Pharmaceuticals's other charges has grown at a 160.0% compound annual growth rate (CAGR), from $4.90M to -$86.10M.
- What does other charges mean?
- Miscellaneous non-operating financial expenses not classified elsewhere.